We join collective action to address antimicrobial resistance
On 21 January 2016, Johnson & Johnson, the parent company of Janssen announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland.
The declaration outlines for the first time how industry and governments can work together to support sustained innovation to address the growing problem of AMR by which bacteria and microbes become resistant to regularly used drugs, making common yet life-threatening infections difficult or even impossible to treat. “We are pleased to be part of this important initiative to combat antimicrobial resistance,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. “Antimicrobials are the backbone of modern medicine, and have played a key role in increasing life expectancy globally.
